Approval · Notice of Compliance 7841 · 2006
ZADITOR: Notice of Compliance 7841
Issued March 27, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7841
- Date
- March 27, 2006
- Company
- Novartis Ophthalmics Novartis Pharmaceuticals (Canada) IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New preservative-free formulation for a single dose unit
- Therapeutic class
- Anti-allergy agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZADITOR | 02279223 | Cancelled Post Market |
Medicinal ingredients
- KETOTIFEN FUMARATE 0.25 MG per ML